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Summary
Here we demonstrate that the ABC transporter ABCG1 plays a critical role in lipid homeostasis by controlling both tissue
lipid levels and the efflux of cellular cholesterol to HDL. Targeted disruption of Abcg1 in mice has no effect on plasma
lipids but results in massive accumulation of both neutral lipids and phospholipids in hepatocytes and in macrophages
within multiple tissues following administration of a high-fat and -cholesterol diet. In contrast, overexpression of human
ABCG1 protects murine tissues from dietary fat-induced lipid accumulation. Finally, we show that cholesterol efflux to
HDL specifically requires ABCG1, whereas efflux to apoA1 requires ABCA1. These studies identify Abcg1 as a key gene
involved in both cholesterol efflux to HDL and in tissue lipid homeostasis.Introduction
The reverse cholesterol transport pathway is critical for the
transfer of excess cholesterol from peripheral tissues back to
the liver for subsequent catabolism and excretion (Fielding and
Fielding, 2001). The initial efflux of cellular cholesterol from
these tissues is thought to be dependent upon extracellular
lipid acceptors that include HDL and/or lipid-poor apoproteins
(Fielding and Fielding, 2001). Although plasma HDL levels are
inversely related to the risk of atherosclerosis (Hayden et al.,
2000), it has yet to be established that the reverse cholesterol
transport pathway plays a critical role in preventing the forma-
tion of cholesterol-loaded macrophages in the artery wall.
ABCG1 and ABCA1 are members of the ATP binding cas-
sette (ABC) superfamily of transmembrane transporters that
pump specific substrates across membranes (Borst and Elfer-
ink, 2002; Dean et al., 2001). Both the ABCG1 and ABCA1
genes are expressed in numerous tissues and are highly acti-
vated by the nuclear receptor LXR (Costet et al., 2000; Ken-
nedy et al., 2001; Lorkowski et al., 2001; Schwartz et al., 2000;
Venkateswaran et al., 2000). Extensive studies have reported
that ABCA1 promotes the efflux of both cholesterol- and cho-
line-containing phospholipids to lipid-poor apolipoproteins that
include apoAI, apoCII, or apoE (Attie et al., 2001; Bortnick et
al., 2000; Oram and Lawn, 2001; Remaley et al., 1995; Schmitz
and Langmann, 2001; Yancey et al., 2003).
The physiological importance of ABCA1 has been estab-
lished from studies on Tangier patients, who have two mutant
ABCA1 alleles (Bodzioch et al., 1999; Brooks-Wilson et al.,
1999; Lawn et al., 1999; Rust et al., 1999). In addition, studiesCELL METABOLISM : FEBRUARY 2005 · VOL. 1 · COPYRIGHT © 2005 Eutilizing Abca1-null mice or bone marrow transplantation pro-
vided important insights into the role of ABCA1 in effluxing
cholesterol to apoA1 (Aiello et al., 2003; Christiansen-Weber
et al., 2000; Haghpassand et al., 2001; McNeish et al., 2000).
Together these studies demonstrated that (1) normal plasma
HDL levels are dependent upon expression of ABCA1 and (2)
macrophage ABCA1 has a minor effect on plasma HDL levels
but is important as a mediator of lipid efflux to exogenous lipid-
poor apoproteins.
In contrast to ABCA1, the function and importance of
ABCG1 in lipid homeostasis in vivo is unknown. In vitro studies
demonstrated that treatment of peritoneal macrophages with
antisense oligonucleotides resulted in decreased expression of
a 110 kDa protein and decreased cholesterol efflux to HDL3
(Klucken et al., 2000). However, the exact cellular and physio-
logical function of ABCG1 remained unclear as the antisense
oligonucleotides also resulted in a significant decline in apoE
secretion (Schmitz et al., 2001).
Both the human and murine ABCG1 genes utilize multiple
promoters and alternative splicing to produce a diverse array
of mRNAs that encode multiple putative protein isoforms that
range from 64–79 kDa (Kennedy et al., 2001; Lorkowski et al.,
2001; Nakamura et al., 2004). It is not known if these isoforms,
which vary only at the amino terminus upstream of the Walker
A motif, form distinct dimers and/or have different functions
in vivo.
We report here both loss-of-function and gain-of-function
studies of Abcg1 using mice with either targeted disruption of
the Abcg1 locus or expressing the human ABCG1 BAC
transgene. The data indicate that ABCG1 plays a critical roleLSEVIER INC. DOI 10.1016/j.cmet.2005.01.002 121
A R T I C L Ein controlling tissue lipid levels by mediating the transfer of cel-
lular cholesterol to HDL.
Results
Characterization of Abcg1-null/lacZ knockin mice
To characterize the physiological function of ABCG1, mice har-
boring a lacZ cassette insertion in exon 3 of the Abcg1 locus
were studied (Figure S1A available with this article online). The
original Abcg1+/− mice were obtained from Deltagen Inc., San
Carlos, California. The β-galactosidase gene, modified to con-
tain a nuclear targeting signal, was under the control of the
Abcg1 promoters, thus allowing facile determination of tissue
and cell type expression and regulation by the endogenous
promoters. PCR analysis of genomic DNA allowed rapid identi-
fication of heterozygous and homozygous mice (Figure S1B).
ABCG1 mRNA was undetectable in the lungs of Abcg1−/− mice
(Figure S1C). However, Northern analysis showed approxi-
mately equal ABCG1 mRNA levels in tissues of wild-type and
heterozygous mice, suggesting that a single allele can maintain
wild-type levels of expression (Figure S1C and data not
shown). Analysis of young Abcg1−/− mice (<7 weeks old) fed a
chow diet failed to detect any significant changes in body
weight, blood lipids, blood chemistry, or tissue pathology (data
not shown). Abcg1+/− and Abcg1−/− mice exhibited normal fer-
tility. In addition, Abcg1−/− pups exhibit normal viability and
growth. These data contrast with the nonproductive mating
and neonatal deaths that have been observed with Abca1−/−
mice (Christiansen-Weber et al., 2000).
Cellular expression and regulation of Abcg1/lacZ
in Abcg1+/− mice
To gain insight into the tissue and cellular expression pattern
of ABCG1, we analyzed frozen tissue sections from Abcg1+/−
mice. Tissue was taken from chow-fed animals and those
whose diet had been supplemented with the LXR ligand
T0901317. This allowed us to characterize both basal and LXR-
activated levels of expression of the gene. LacZ was detected
in numerous tissues of chow-fed Abcg1+/− mice, with particu-
larly high levels being observed in macrophages in the ileum,
liver, and lung (Figures 1A, 1C, and 1E). Scattered lacZ-positive
stained cells were also observed in both the follicles and inter-
follicular regions of the spleens of chow-fed animals (Figure
1G), consistent with the expression of ABCG1 in both macro-
phages and lymphocytes. Significant lacZ activity was also
noted in endothelial cells lining the vasculature of the liver and
kidney medulla (Figures 1C, 1D, and 1L). Epithelial cells that
comprise the distal collecting tubules of the kidney were also
positive (Figure 1I–1L). The data of Figure 1 (panels B, F, H,
and J) show that administration of the LXR ligand T0901317 to
Abcg1+/− mice increased lacZ activity in a number of tissues,
but especially the ileum, lung, spleen, and kidney. These analy-
ses identified previously unknown expression patterns for
ABCG1 outside of macrophages.
The absence of lacZ activity in hepatocytes of Abcg1+/− or
Abcg1−/− mice fed chow or chow supplemented with T0901317
(Figures 1C and 1D; data not shown for Abcg1−/−) was unex-
pected and suggested that lacZ expression in hepatocytes
might be below the level of detection. Consequently, we per-
formed in situ hybridization studies utilizing liver sections from
wild-type mice fed chow or chow + T0901317 (Figure 2). All122Figure 1. LacZ expression in tissues of Abcg1+/− mice
Abcg1+/− mice were fed a normal diet or a diet supplemented with T0901317 for
10 days. Sections of the ileum (A and B), liver (C and D), lung (E and F), spleen
(G and H), and kidney (I–L) from Abcg1+/− mice were stained for lacZ activity
(blue) as described. Macrophages (M), enterocytes (Ent), epithelial cells (Epi),
Kupffer cells (K), distal collecting tubules (DCT), and endothelial cells (EC) are
indicated. Lymphocytes (L) are present in the spleen follicles (F). Bars: 100 m
(A–F, I–K) or 20 m (L).CELL METABOLISM : FEBRUARY 2005
ABCG1 regulates tissue lipid homeostasisFigure 2. In situ hybridization studies indicate that
ABCG1 mRNA is expressed in hepatocytes
Wild-type mice were fed chow (left panels) or chow +
T0901317 (50 mg/kg/day) (right panels) for 10 days.
Liver sections were incubated with antisense or
sense probes, as described in Experimental Pro-
cedures. The bright field (BF) and dark field (DF)
from identical sections identify the cell nuclei and
the signal from the antisense or sense probes,
respectively. (A)–(D) and (G)–(J) are shown at 125×
magnification. Positive signals that identify ABCG1
mRNA in the bright field (E and F; 500× magnifica-
tion) are indicated by arrows.CELL METABOLISM : FEBRUARY 2005 123
A R T I C L Eliver sections contained similar concentrations of cells, as
judged by nuclear staining and analysis under bright field (Fig-
ures 2A, 2B, 2G, and 2H). The data of Figure 2 (panels C and
E) show that ABCG1 mRNA is expressed at very low levels
throughout the livers of wild-type mice fed a chow diet. As
expected, ABCG1 mRNA levels increased significantly following
administration of T0901317 to the mice (Figures 2D and 2F).
Importantly, most, if not all, hepatic cells expressed ABCG1
mRNA (Figures 2C–2F). No signal was observed when a sense
oligonucleotide was utilized (Figures 2I and 2J). Since hepato-
cytes represent the major cell type in the liver, these data, to-
gether with the data of Figure 1, demonstrate that ABCG1 is
expressed in Kupffer cells, endothelial cells, and hepatocytes.
Abcg1−/− mice fed a high-fat/high-cholesterol diet fail
to maintain normal tissue lipid levels
Given that no striking phenotype was noted in young Abcg1-
null animals on a standard diet, and ABCG1 is activated by
LXR in response to lipid loading in macrophages, we fed mice
a diet high in fat and cholesterol. If ABCG1 is involved in the
normal efflux of lipids from cells, then lipid accumulation
should be observed in Abcg1-null animals. To test this hypoth-
esis, age- and sex-matched animals were fed a diet containing
21% fat and 1.25% cholesterol for nine weeks. Despite the fact
that there was no change in plasma lipid levels (Figure S2), the
Abcg1-null mice displayed profound changes in histology of
several tissues. For example, visual examination of the lungs
of the Abcg1-null mice indicated that this organ was abnormal
as the lung surface appeared highly irregular and contained
numerous large indentations/crevices. In addition many pale
foci, indicative of lipid accumulation, were observed (data not
shown). Given the gross physical difference between the lungs
of the Abcg1-null and wild-type animals, we were prompted to
examine the pathology of this organ in more detail. In particu-
lar, it was of interest to determine if the pale foci were indeed
the result of lipid accumulation.
Consequently, frozen lung sections were prepared from mice
fed the high-fat/high-cholesterol diet and stained for β-galacto-
sidase activity. As expected, the lungs of wild-type mice
showed no evidence of lacZ expression or lipid accumulation
(Figures 3Aa and 3Ab). In contrast, not only did all macro-
phages in the lungs of Abcg1-null mice stain positive for lacZ,
but it was apparent that a significant number were localized
to the subpleural region of the lung (Figure 3Ac). Of greater
significance was the fact that this was the same area that
showed massive neutral lipid accumulation, as seen by oil red
O staining (Figure 3Ad). The subpleural region of the lungs of
Abcg1−/− mice also contained a plethora of cholesterol clefts,
many lacZ-positive multinucleated giant cells, and lympho-
cytes (Figures 3Ba and 3Bb). LacZ expression was also ob-
served in the epithelial cells that line the bronchioles and endo-
thelial cells that line the blood vessels (Figure 3Bc). Taken
together, these results implicate a role for ABCG1 in both ma-
crophages and lymphocytes in response to a high-fat/high-
cholesterol diet.
Ultrastructural analysis using electron microscopy revealed
the presence of classic macrophage foam cells in the subpleu-
ral region of Abcg1-null lungs (Figure 3C). In addition to large
numbers of lipid droplets, many foam cells contained remark-
able numbers of cholesterol clefts (Figure 3C), consistent with
a severe defect in the normal processing of this lipid. This is124significant because it suggests that ABCG1 is not involved in
the uptake of lipid but rather in the subsequent processing and
excretion of the lipid from these cells. Finally, a pneumocyte
(alveolar) type II cell, which functions to secrete lamellar bodies
containing surfactant, was easily discerned in the micrograph
(Figure 3C). A few lamellar bodies can be seen within the mac-
rophage, consistent with the normal uptake of these bodies by
phagocytic cells (Morgenroth, 1988).
Excessive neutral lipid accumulation in response to the high-
fat/high-cholesterol diet was not limited to the lung or to ma-
crophages. Lipid accumulation and oil red O staining was con-
sistently far greater in the livers of Abcg1-null as compared to
wild-type animals (Figure 3Db versus 3Da). However, unlike the
lung where lipid accumulation was restricted to macrophages,
the neutral lipids accumulated in both resident macrophages
(Kupffer cells) and hepatocytes (Figure 3D). These data suggest
that the very low mRNA levels of ABCG1 that are expressed in
murine (Figure 2) or rat hepatocytes (Hoekstra et al., 2003) are
critical for lipid homeostasis.
The ileum of control and Abcg1-null mice fed the high-fat/
high-cholesterol diet did not stain with oil red O (Figure S3),
suggesting that lipid absorption may be independent of
ABCG1 expression that was limited to macrophages within the
lamina propria (Figures 1A and 1B).
Examination of kidney tissue also revealed a complete ab-
sence of oil red O staining (data not shown). In this regard, it
may be significant that ABCG1/lacZ expression in the kidney
was restricted to epithelial and endothelial cells and no evi-
dence of lacZ-positive macrophages was observed (Figures
1I–1L). In contrast to Abca1-null mice (Christiansen-Weber et
al., 2000), the kidneys of Abcg1−/− mice showed no evidence
of glomerulonephritis or inflammatory cell infiltration.
Characterization of the human ABCG1-transgenic mice
Based on the results with Abcg1−/− mice we hypothesized that
transgenic mice harboring a BAC containing the intact human
ABCG1 gene would be protected from the effects of the high-
fat diet. Consequently, we generated C57Bl/6-transgenic mice
that contained a single copy of a human BAC (145 kb). The
human ABCG1 gene (100 kb) and 35 kb 5# and 10 kb 3# of
the gene are contained within this BAC. In order to determine
whether the human ABCG1 gene was expressed and regulated
in appropriate tissues, transgenic mice and wild-type litter-
mates were fed chow or chow supplemented with the LXR li-
gand T0901317. The data of Figure 4 (panels A–E) show that,
in response to T0901317, the levels of both the human and
murine ABCG1 mRNAs were induced 5- to 14-fold in the lung,
liver, kidney, ileum, and spleen. Real-time quantitative PCR uti-
lizing RNA isolated from murine or human macrophages (RAW
and THP1, respectively) show that the probes were highly spe-
cific (Figure 4F). Importantly, the data of Figures 4A–4E demon-
strate that overexpression of the human ABCG1 mRNA did not
affect the basal or the T0901317-dependent induction of the
murine Abcg1 gene. Since T0901317 induced the expression
of the human ABCG1 gene, we conclude that the BAC clone
contained the appropriate cis elements necessary for tran-
scriptional activation of human ABCG1 in response to LXR-
specific ligands.CELL METABOLISM : FEBRUARY 2005
ABCG1 regulates tissue lipid homeostasisFigure 3. LacZ expression and lipid accumulation in Abcg1-null and control mice fed a high-fat/high-cholesterol diet
A) Abcg1−/− and Abcg1+/+ mice were fed a high-fat/high-cholesterol (HF/HC) diet for 9 weeks. Cryosections of the lungs (panels a–d) were stained for lacZ (panels a
and c) or for neutral lipid using oil red O (panels b and d), as indicated.
B) Lungs of the HF/HC-fed Abcg1−/− mice contain cholesterol clefts (CC), giant cells (GC) (panel a), and lacZ-positive lymphocytes (L) (panel b). LacZ-positive
macrophages (M), epithelial cells (Epi), and endothelial cells (EC) are also evident (panel c).
C) Electron micrograph of a lipid-loaded macrophage present in the subpleural lung area of an Abcg1−/− mouse fed the HF/HC diet. A few of the lipid droplets (LD),
cholesterol clefts (CC), and lamellar bodies (white arrows) are indicated. A pneumocyte type II (PnuII) cell is shown. Magnification = 15,000×.
D) Cryosections of livers taken from HF/HC-fed wild-type (panel a) and Abcg1−/− (panel b) mice were stained with oil red O to identify neutral lipid. Central vein (CV).Tissue lipid profiles of Abcg1-null
and ABCG1-transgenic mice
The data of Figure 5 show the lipid profiles of the lungs and
livers of wild-type, Abcg1-null, and human ABCG1-transgenic
mice fed chow or the high-fat/high-cholesterol diet for 9
weeks. No significant differences in the cholesterol, triglycer-
ide, or phospholipid levels were observed in these tissues of
chow-fed animals (Figure 5). In contrast, cholesterol, triglycer-
ide, and phospholipid concentrations were significantly in-
creased in the livers and lungs of Abcg1-null mice fed the
high-fat/high-cholesterol diet, as compared to their wild-type
littermates (Figure 5).
In contrast to the data with the Abcg1-null mice, the levels
of total cholesterol, cholesterol esters, and phospholipids were
significantly lower in the livers and lungs of the transgenic mice
fed the high-fat diet as compared to their wild-type littermates
(Figure 5). Thus, the human ABCG1-transgene protected these
tissues from diet-induced lipid accumulation. Interestingly,
plasma lipid levels were similar in ABCG1-transgenic, Abcg1-
null, and their littermates fed the high-fat/cholesterol diet (Fig-
ure S2), suggesting that the function of ABCG1 is different from
other ABC transporters, such as ABCA1, ABCG5, and ABCG8,
that are also activated by LXR.CELL METABOLISM : FEBRUARY 2005As noted above, the tissues of young (%7 weeks of age)
Abcg1-null mice fed chow showed no evidence of lipid accu-
mulation. However, examination of the lungs of chow-fed
Abcg1-null mice of R15 weeks of age indicated the presence
of oil red O-positive lipid; by the age of 6 months, the lungs of
chow-fed Abcg1-null mice contained giant cells, multiple lym-
phocytes, and oil red O-positive macrophages (Figure S4A–
S4C). In contrast, the livers of these Abcg1−/− mice and the
lungs and livers of their wild-type littermates fed chow showed
no evidence of neutral lipid accumulation (Figure S4D and data
not shown). Together, these data demonstrate that ABCG1
plays a critical and heretofore unrecognized role in maintaining
normal cellular lipid levels in both chow-fed mice, but espe-
cially in mice following administration of a high-fat/high choles-
terol diet.
Dysregulation of cholesterol biosynthetic
genes in Abcg1-null animals
Given the critical role for LXR in maintaining proper lipid ho-
meostasis of the liver and the fact that ABCG1 is a target gene
of LXR, we were prompted to examine the regulation of genes
involved in both fatty acid and cholesterol biosynthesis in wild-
type and Abcg1−/− animals. Abcg1−/− animals fed a standard125
A R T I C L EFigure 4. Expression and regulation of the human ABCG1 in BAC-transgenic
mice
Transgenic mice (Tg) and their wild-type littermates (four or five mice/group) were
fed chow or chow supplemented with T0901317 (50 mg/kg/day) for 10 days.
RNA was isolated from the indicated tissues (A–E) and murine and human
ABCG1 mRNA levels determined using quantitative real-time PCR using probes
against the murine (M) or human (H) ABCG1 and normalized to cyclophilin
(mean ± SEM, n = 4 or 5 mice/group). ABCG1 mRNA was also quantified from
murine RAW267 or human THP1 cells that had been incubated in the presence
of T0901317 (1 M) for 24 hr (F).chow diet displayed a dysregulation of the genes involved in
cholesterol biosynthesis and LDL endocytosis; hepatic mRNA
levels were significantly increased in the Abcg1-null mice (Fig-
ure 6A). In addition to the induction of the genes of cholesterol
biosynthesis, a 2-fold increase of SREBP1c mRNA was ob-
served in the chow-fed Abcg1−/− animals (Figure 6B). SREBP1c
was further induced upon feeding animals the high-fat/high-
cholesterol diet irrespective of the genotype (Figure 6B). The
induction of SREBP1c is consistent with previous studies that
demonstrate that in mice fed a high-cholesterol diet, SREBP1c
is induced through activation of LXR (Repa et al., 2000). In the
presence of excess sterols, LXR activation induces SREBP1c
to promote the production of fatty acids that are used as sub-
strates in the esterification of excess free cholesterol by acyl-
CoA:cholesterol acyltransferase (Repa et al., 2000). Figure 6C
shows that both hepatic acetyl-CoA carboxylase (ACC) and
sterol-CoA destaturase (SCD1) were induced w2-fold and 1.4-
fold, respectively, in Abcg1−/− mice fed a chow diet. Upon
feeding a high-fat/high-cholesterol diet, there was a 5-fold acti-
vation of SCD1 independent of genotype and a 2-fold induc-126tion of ACC in wild-type mice. Thus, although there is no evi-
dence for lipid accumulation in the livers of Abcg1−/− mice on
chow, it is clear that there is a dysregulation of the genes in-
volved in cholesterol metabolism. This may account for the ac-
tivation of SREBP1c and the induction of the genes involved in
fatty acid synthesis. An increase in cholesterol levels can also
lead to the activation of LXR and SREBP1c and SREBP1c-
target genes in an effort to buffer the effect of toxic free choles-
terol within the cell (Peet et al., 1998b; Repa et al., 2000). How-
ever, under extreme conditions of lipid loading, as is seen when
the animals are fed the high-fat/high-cholesterol diet, the
genes of cholesterol biosynthesis are repressed and those of
fatty acid synthesis, especially SCD1, are highly induced re-
gardless of genotype. Under these conditions, the capacity of
the Abcg1−/− mice to efficiently process and remove excess
lipid is likely defective, leading to the observed increase in tis-
sue lipids.
ABCG1 is required for maximal efflux of cholesterol
from macrophages to HDL
From the histological data it is clear that ABCG1 is required to
maintain proper lipid homeostasis in macrophages and hepa-
tocytes. Given that ABCG1 was both expressed in macro-
phages and is a target gene for LXR, we decided to test if the
lipid accumulation in the cells of Abcg1-null animals was due
to a defect in the transport of cholesterol out of the cells to
exogenous lipid acceptors. Consequently, peritoneal macro-
phages were isolated from wild-type and Abcg1-null mice and
cholesterol efflux to HDL or apoA1 determined. Consistent with
a role for LXR in reverse cholesterol transport, treatment of
wild-type macrophages with ligands for LXR and RXR signifi-
cantly increased the rate of efflux of cholesterol to both HDL
and apoA1 (Figures 7A and 7B). However, in contrast to these
results, treatment of Abcg1-null cells with LXR/RXR ligands
failed to stimulate cholesterol efflux to HDL (Figure 7A). This
effect was surprisingly specific for HDL given that cholesterol
efflux to apoA1 was not affected in the Abcg1-null cells (Figure
7B). This defect in Abcg1-null cells was not a result of an im-
pairment of the LXR/RXR pathway since treatment of the
Abcg1-null cells with T0901317 and LG100153 resulted in nor-
mal activation of ABCA1 mRNA levels (data not shown).
In parallel studies we measured the rate of cholesterol efflux
from Abca1-null and control peritoneal macrophages to either
HDL3 or apoA1. The data of Figure 7C demonstrate that cho-
lesterol efflux to HDL3 increased following treatment of either
wild-type or Abca1-null cells with T0901317 and LG100153. In
contrast, cholesterol efflux to apoA1 was attenuated signifi-
cantly in both untreated and LXR-activated Abca1-null macro-
phages (Figure 7D). Based on these studies, we conclude that
ABCG1, but not ABCA1, has a specific role in mediating the
efflux of cholesterol from macrophages to HDL following acti-
vation of LXR/RXR. In contrast, ABCA1 functions to transfer
cellular cholesterol to lipid-poor apoA1. Very recent studies
also demonstrated that cholesterol efflux to HDL was in-
creased following transient transfection of cells with cDNAs en-
coding ABCG1 (Nakamura et al., 2004; Wang et al., 2004). In
preliminary studies, we have failed to observe differences in
the efflux of choline-labeled or oleic acid-labeled lipids from
Abcg1-null and wild-type peritoneal macrophages (data not
shown).
Taken together, the current mechanistic studies are consis-CELL METABOLISM : FEBRUARY 2005
ABCG1 regulates tissue lipid homeostasisFigure 5. Tissue lipid levels are altered in ABCG1−/− and Abcg1-transgenic mice
Male Abcg1−/− (■; K) and their wild-type (,; W) littermates or transgenic mice ( ; T) and their wild-type littermates (Q; w) (8–9/group) were fed normal chow or the
high-fat/high-cholesterol (HF/HC) diet for 9 weeks. Tissues were removed and lipids analyzed as described in Experimental Procedures. Values shown are mean ±
SEM, n = 8 or 9.
*, p value (determined by Student’s t test) < 0.001 between HF/HC-fed mice and their chow-fed littermates.
#, p < 0.001 between the indicated mice fed the HF/HC diet.tent with the observed accumulation of lipid droplets in macro-
phages and hepatocytes of Abcg1-null mice and the protective
role of human ABCG1 in transgenic mice.
Discussion
The availability of Abcg1−/−/lacZ knockin and human ABCG1
BAC-transgenic mice has provided important tools to investi-
gate the cellular and tissue distribution and function of the pro-
tein. Young Abcg1−/− mice were indistinguishable from wild-
type littermates when fed a normal chow diet. In contrast, the
lungs of older Abcg1-null mice (15–24 weeks) accumulate neu-
tral lipid, multinucleated giant cells, and lymphocytes (Figure
S4). However, when young Abcg1−/− mice were challenged
with a high-fat/high-cholesterol diet, this lipid imbalance was
greatly accelerated; the Abcg1-null mice failed to control cellu-
lar lipid levels and accumulated massive amounts of choles-
terol, triglycerides, and phospholipids in multiple organs, with-
out changes in plasma lipids and lipoproteins. Consequently
we conclude that ABCG1 has (1) a critical role in regulating
lipid homeostasis in multiple tissues and (2) no significant role
in regulating the levels of plasma lipoproteins.
In an earlier study, it was reported that plasma HDL and cho-CELL METABOLISM : FEBRUARY 2005lesterol ester levels were reduced following infusion of mice
with adenovirus expressing ABCG1 (Brewer and Santamarina-
Fojo, 2003). Such changes in plasma lipids may result from
inappropriately high overexpression of ABCG1 in hepatocytes,
a cell type that normally expresses low levels of ABCG1 (Hoek-
stra et al., 2003). The current observation that massive tissue
lipid accumulation occurs in the Abcg1-null mice in the ab-
sence of changes in plasma lipid levels may be relevant to clin-
ical disease.
Previous studies reported that either cholesterol or oil red
O-positive stained lipids accumulate in the liver, brain, and/or
macrophages of Lxrα−/− or Lxrαβ double knockout mice (Al-
berti et al., 2001; Peet et al., 1998a; Tangirala et al., 2002).
Such changes in lipid levels likely result from altered expres-
sion of multiple genes. The current study identifies ABCG1 as
an important LXR target gene that plays a critical role in main-
taining lipid homeostasis in a variety of cells and tissues. Other
LXR-target genes that contribute to changes in lipid levels in-
clude ABCA1, ABCG5, and ABCG8 since disruption of the lat-
ter three genes results in altered plasma lipid levels (McNeish
et al., 2000; Yu et al., 2002) and accumulation of cholesterol
(or oil red O staining) in the lungs, liver, and/or brain (McNeish
et al., 2000; Wang et al., 2002; Yu et al., 2002).127
A R T I C L EFigure 6. Dysregulation of hepatic genes involved in cholesterol and fatty acid
synthesis in Abcg1−/− mice
Wild-type (WT) and Abcg1−/− (KO) mice were fed chow or the high-fat/high-cho-
lesterol diets for 9 weeks prior to isolation and quantification of hepatic mRNA
levels using quantitative real-time PCR. Wild-type and Abcg1−/− on chow,
Abcg1−/− on HF/HC (n = 5 per group), wild-type on HF/HC (n = 4). Values shown
are mean ± SEM. mRNA expression in the wild-type mouse fed chow was arbi-
trarily designated as 1.0. *p < 0.05; **p < 0.01; ***p < 0.001 for experimentals
versus chow-fed wild-type mice. p values were determined using Student’s t test.128Figure 7. Lipid efflux from peritoneal macrophages to HDL is impaired in Abcg1−/−
but not in Abca1−/− cells
Pooled peritoneal macrophages were isolated from three to seven mice of the
same genotype and then incubated in quadruplicate in the presence or absence
of LXR/RXR ligands (1 M T0901317; 100 nM LG100153). Cholesterol efflux was
then determined in the presence of either HDL (50 g/ml) or apoA1 (15 g/ml),
as described in Experimental Procedures. Values are mean ± SD of quadruplicate
assays. Data are representative of two or more experiments.
*p < 0.01; **p < 0.02; ns, not significantly different by Student’s t test.The relative importance of ABCG1 and ABCA1 in promoting
lipid efflux from macrophages and thus attenuating foam cell
formation in vivo is unknown. We hypothesize that the relative
concentration of HDL and apoA1 in the sub-intimal space of
the artery wall may be important. If, as seems likely, HDL levels
are far greater than lipid-poor apoA1 levels, then ABCG1 mayplay an important role in mediating cholesterol efflux from ma-
crophages and preventing cholesterol ester accumulation and
foam cell production. Studies to delineate the importance of
ABCG1 in this process in vivo are currently underway. Since
the cellular localization of ABCG1 is not known, it remains to
be determined whether ABCG1 directly facilitates the transfer
of cellular cholesterol from the plasma membrane to HDL or
indirectly affects this process by modulating intracellular lipid
traffic.
Finally, our data indicate that the absence of ABCG1 results
not only in the accumulation of cholesterol esters in macro-
phages and the liver but also in the accumulation of triglycer-
ides and phospholipids. Identification of the molecular mecha-
nism that results in the accumulation of these latter lipids in
the tissues of Abcg1-null mice may provide an as yet unknown
link between ABCG1 and overall lipid metabolism.
Experimental procedures
Materials
ApoA1 was from Intracell. Bovine serum albumin and X-gal(5-bromo-4-
chloro-3-indolyl β-D-galactopyranoside) and 3H-cholesterol (Sigma; 56 Ci/CELL METABOLISM : FEBRUARY 2005
ABCG1 regulates tissue lipid homeostasismM) were from Sigma. Human HDL (d = 1.063–1.21) was isolated by ultra-
centrifugation. T0901317 was from Cayman Chemicals, Ann Arbor, Michigan.
Animals
All animals were housed under 12 hr/12 hr light/dark conditions. Abcg1-
null/LacZ knockin mice were generated by Deltagen Inc., California, using
a targeting vector that contained a 7-kb IRES-LacZ-Neo-pA cassette
flanked by 7 kb of 5# and 1.4 kb of 3# mouse genomic DNA. Homologous
recombination between the vector and the wild-type Abcg1 allele results in
deletion of 21 bp, encoding seven amino acids (GPSGAGK), that comprise
the Walker A motif in exon 3. Chimeric mice were produced from embryonic
stem cells derived from the 129/OlaHsd mouse substrain. F1 mice were
generated by breeding with C57Bl/6 females, and subsequent generations
were crossed once with BABL/cJ mice before multiple (5) back crossing
with C57Bl/6. Homozygote (−/−) mice were obtained by crossing heterozy-
gote (+/−) animals.
Human ABCG1 BAC-transgenic mice were generated at UC Irvine, Cali-
fornia, following standard procedures using a 145 kb purified BAC (clone
KB1430A10). This clone contains 100 kb corresponding to the full-length
human ABCG1 gene (unpublished data) on chromosome 21 plus additional
nucleotides corresponding to 35 kb 5# and 10 kb 3# of the gene. Briefly, the
BAC was isolated by CHEF gel analysis and purified for injection using
Qiagen maxi Prep kit, followed by cesium chloride purification and ultracen-
trifugation through an ultrafree filter. The purified BAC fragment was quanti-
fied using agarose gel electrophoresis, and sets of 144 C57BL/6 eggs were
injected with 20 ng of the purified DNA. Twelve pups were genotyped with
DNA extracted from tail pieces, followed by subsequent PCR amplification
of the 5# UTR, individual exons 1–23 (Kennedy et al., 2001), and the 3# UTR
of the ABCG1 gene, and flanking region. Three founder mice were obtained.
Southern blot and PCR analysis demonstrated that each founder contained
a single insertion of the BAC. Offspring from each founder expressed the
human ABCG1 mRNA in multiple tissues. F1 mice were generated by
breeding with C57BL/6 females. Subsequent generations were crossed
once with BABL/cJ mice before multiple (4) backcrossing with C57BL/6.
One line was chosen for more detailed studies.
Diets
Mice were fed for nine weeks either normal chow or a high-fat/high-choles-
terol diet (Research Diet; Clinton/Cybulsky D12108; contains 21% fat and
1.25% cholesterol, w/w). Alternatively, mice were fed normal chow supple-
mented with T0901317 for 10 days (250 mg T0901317 per kg diet) to pro-
vide w50 mg T0901317/kg body weight/day.
RNA isolation and analysis
Tissues, collected from mice fed a chow or high-fat/high-cholesterol diet,
were homogenized in Trizol reagent (Invitrogen) for RNA isolation. cDNA
was generated from 5 g of DNase1-treated RNA using Superscript II and
Random hexamers (Invitrogen). Real-time PCR was done with Sybr green
reagent (Bio-Rad, iQSybr green supermix), using the MyiQ Real-time PCR
detection system (Bio-Rad). Primer sets were taken from Yang et al. (2001)
or are available on request. Values were normalized to GAPDH and calcu-
lated using the comparative CT method. For Northern blots, 20 g of total
RNA were resolved on a MOPS/formaldehyde gel and transferred to a nylon
membrane and probed with a 32P-labeled 3# UTR probe against murine
ABCG1 and cyclophilin.
Lipid analysis
Plasma lipid levels of Abcg1−/− and ABCG1 transgenic mice and their wild-
type littermates were assayed enzymatically, as described (Zhang et al.,
2004). Tissue lipids were extracted into CHCl3 by a modified Folch method,
resolubilized in water, and quantitated using kits for cholesterol, triglyceride,
or phospholipid using the accompanying protocols (Wako Chemicals USA,
Richmond, Virginia) (Carr et al., 1993).
Peritoneal macrophages and lipid efflux assays
Peritoneal macrophages were obtained from thioglycollate-treated mice as
described (Venkateswaran et al., 2000). Macrophages were plated in 48 well
plates (0.25 × 106 cells/well) in media containing 10% FBS and allowed to
adhere overnight. The cells were washed and incubated for an additional
24 hr in fresh media, re-washed, and incubated in media A (DMEM + 0.2%CELL METABOLISM : FEBRUARY 2005BSA) supplemented with an ACAT inhibitor (58–035; 2 g/ml) and 3H-cho-
lesterol (1 Ci/ml). After 24 hr the cells were washed with PBS and incu-
bated in fresh media A for an additional 4 hr equilibration period. Where
indicated, the cells were incubated with T0901317 (1 M) and LG100153
(100 nM) during radiolabeling and equilibration. To determine cholesterol
efflux, the cells were rinsed three times and then incubated for 4 hr in media
A supplemented, where indicated, with either HDL or HDL3 (50 g/ml) or
apoA1 (15 g/ml). The media was removed, the cells washed with PBS,
and the radioactive content of the media and cells determined as described
(Venkateswaran et al., 2000). Lipid efflux to the media was linear for >8 hr
(data not shown). Cholesterol efflux was determined by dividing the radio-
active content of the media by the sum of the radioactivity in the cells and
media. The basal efflux (% cholesterol that effluxes to media A) was
subtracted from the values obtained in the presence of HDL or apoA1.
LacZ expression and Oil red O staining
Tissues were removed and placed in 4% paraformaldehyde in PBS for 4 hr.
Briefly, the tissues were rinsed with PBS and cryoprotected by soaking in
20% sucrose in PBS at 4°C overnight. The tissues were then snap frozen
in OCT and stored at −80°C. Ten micrometer frozen sections were prepared
on glass slides (Fisher super frost plus) and stored at −80°C. To detect
β-galactosidase activity the glass slides were incubated for 12–16 hr at
23°C in the presence of X-gal (5-bromo-4-chloro-3-indolyl β-D-galactopyra-
noside). The slides were washed three times with PBS/0.1% Tween-20,
counterstained with nuclear fast red (unless otherwise indicated), rinsed in
water, dehydrated, and mounted under coverslips using a xylene-based
mounting media. Alternatively, frozen sections were incubated with oil red
O, washed with 60% isopropanol, and counterstained with hematoxylin.
Electron microscopy
Thin section electron microscopy was carried out as described (Tamminen
et al., 1999).
In situ hybridization of adult murine tissues
Ten-week-old male C57BL/6 mice were fed a diet consisting of either chow
(TD 5001) or chow with 50 mpk synthetic LXR agonist T090137 ad libitum
for 10 days. Paraformaldehyde perfusion and fixation of the mice were per-
formed as previously described (Lindsell et al., 1995). Tissues were re-
moved and frozen in OCT (VWR) after soaking for 2 days in cryoprotection
buffer at 4°C. Twenty micrometer sections were placed directly on Su-
perfrost slides (Fisher) after cryo-sectioning and thaw-mounted followed by
60 min under vacuum and storage at −70°C until hybridization. Sense and
antisense cRNA probes were made from the plasmid pCI-Neo- Abcg1 con-
taining a 905 bp fragment of the ABCG1 carboxy terminus and 3# UTR as
described above using [α-33P]UTP and the MAXIscript in vitro transcription
kit (Ambion). Alkaline hydrolysis of the cRNA probe was performed to yield
a final fragment length of 0.3 kb. Hybridization was carried out exactly as
described (Lindsell et al., 1995) except that the proteinase K treatment was
10 min and the RNase treatment was 35 min for all tissues. Labeled cRNA
probe (5 × 107 cpm) was used per slide in the hybridization, and signal
detection on X-ray film was performed for 24 and 72 hr with Kodak BioMax
MR film at −70°C. Emulsion dipped slides were stored for 2 weeks at 4°C
before exposure. Grains were visualized by bright and dark field micro-
scopy.
Supplemental data
Supplemental data include four figures and are available with this article
online at http://www.cellmetabolism.org/cgi/content/full/1/2/121/DC1/.
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